Bedside monitoring for infected pancreatic collections
Part of Digestive system clinical trials.
This trial studies a new way to monitor infected pockets of dead tissue in the pancreas (called walled-off necrosis) right at the bedside during standard drainage treatment. It may help doctors track changes in the infection more closely, which could improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of walled-off pancreatic necrosis seen on an imaging test like CT, MRI, or EUS.
- Your doctor must suspect or confirm that the necrosis is infected (for example, you have a fever, high infection markers, or a positive culture).
- You are already scheduled to have a drainage procedure (percutaneous drainage) as part of your standard care.
- You need to be able to give informed consent yourself or have someone who can consent for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new freezing tool to remove dead tissue from the pancreas after acute pancreatitis. It might help you if you have a large, painful collection of dead tissue that needs to be cleaned out through a tube down your throat.
This study compares two ways to treat a pancreatic infection pocket (walled-off necrosis): removing dead/infected tissue right away versus starting with drainage and escalating if needed. It may help find the safest, most effective approach for getting the infection under control.
This trial tests a new device (Endorotor) against standard methods to clean out infected fluid collections in the pancreas after severe pancreatitis. It aims to see if the new approach works better and costs less.
This trial collects blood samples from people with infected pancreatic necrosis to find patterns that help diagnose the condition. The goal is to reduce the need for invasive tests and start treatment faster.
This study looks at how tiny particles in blood (“exosomes”) carry signals between cells in people having pancreatic surgery. The goal is to understand these signals in different pancreatic conditions and treatment situations, which may help future care.
This study tests a new blood test that looks for signs of infection in people with severe pancreatitis. It aims to more accurately detect if the dead pancreatic tissue has become infected, which could help doctors decide on treatment earlier.
Hear when a new Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.